iX Biopharma is a listed, specialty pharmaceutical and nutraceutical company focusing on the development and commercialisation of therapies for diseases of the central nervous system using novel, patent-protected formulations for sublingual delivery.
iX Biopharma’s pipeline of products under development includes Wafermine (ketamine wafer) and BnoX (buprenorphine wafer) for pain management. iX Biopharma’s drugs for the treatment of erectile dysfunction, Wafesil, a sublingual sildenafil wafer, and Silcap, have been registered in Australia. iX Biopharma has developed Xativa, the world’s first freeze-dried sublingual medicinal cannabis wafer.
The Group’s nutraceuticals division, Entity Health Limited, is engaged in the development and commercialisation of nutraceutical products.
Subsidiaries:
iX Syrinx ( https://www.ixsyrinx.com )
Entity health ( https://www.entity-health.com )
Company Details
- Employees
- 11
- Address
- 1 Kim Seng Promenade, 14-01,australia
- Phone
- 65 62352270
- in****@****rma.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- ixbiopharma.com
- Keywords
- Patented Sublingual Drug Delivery Technology, Novel Drug Delivery Systems, Pain Management, Therapies for diseases of the central nervous system.
- HQ
- Singapore, Singapore
Ix Biopharma Questions
Ix Biopharma's helpline number is 65 62352270
Ix Biopharma's website is ixbiopharma.com
Ix Biopharma's LinkedIn profile is https://sg.linkedin.com/company/ix-biopharma
Ix Biopharma has
11 employees.
View email and phone details for 11
employees at Ix Biopharma.
Ix Biopharma's industry is
Pharmaceutical Manufacturing
Ix Biopharma's support email address is info@ixbiopharma.com
Ix Biopharma's categories are Pharmaceutical Manufacturing
